Menopausal hormone decline contributes significantly to the risk of osteoporosis. Therapies for treating osteoporosis, such as hormone replacement therapy (estrogen or combination estrogen-progestins), inhibit bone resorption. Both animal and human studies demonstrate phytoestrogenic soy isoflavones favorably impact bone health.
Isoflavones are a subclass of flavonoids with a chemical structure similar to 17[beta]-estradiol, the most potent, naturally occurring estrogen. Isoflavones bind to estrogen receptors, affecting estrogen-regulated processes, and are therefore referred to as phytoestrogens (plant estrogens). Isoflavones are extremely limited in nature, found in nutritionally significant amounts only in soy. The main isoflavones in soybeans are genistein and daidzein. A third isoflavone, glycitein, is also present, although in much smaller amounts.
Potential health benefits of isoflavones
Isoflavones are proposed to have health benefits in a variety of human conditions, including coronary heart disease, menopause, osteoporosis, endocrine-responsive cancers, and cyclic mastalgia (monthly breast pain). Many isoflavones have estrogen-like properties and, because of a favorable side-effect profile, may be ideal alternatives to hormone replacement therapy with respect to cardiovascular benefits. Increased isoflavone intake affects estrogen metabolism by altering the steroid hormone concentrations and menstrual cycle length, thereby demonstrating a potential to reduce the risk for breast carcinoma.
Isoflavone Menopause treatment
When given in adequate doses to postmenopausal women, soy that contains isoflavone improves menopausal symptoms and related quality of life. Studies on the benefits of soy for relieving menopausal symptoms have produced mixed results. In a new study, a research group used a standardized soy product which contains 160 milligrams of total isoflavones, soy-derived antioxidants. 43 postmenopausal women were assigned to the soy product or placebo daily for three months. The average age of the women was 55 years and they had been off hormone replacement therapy for at least six months prior to entering the study. All of the women completed a menopause-specific quality-of-life questionnaire at the beginning of the study and again after 6 weeks and 3 months. Compared with placebo, soy therapy led to a 40-percent reduction in psychosocial complaints involving mood and depression, a 36-percent reduction in hot flashes and night sweats, as well as and a 30-percent reduction in other physical symptoms, primarily low energy.
NPN# 80015193
Each Capsule Contains:
Soybean Extract............................................150mg
Contains Soy Isoflavone (40%)...................60mg
Non- medicinal ingredients:
Microcrystalline cellulose, Magneisum stearate
No preservatives, artificial color, dairy, eggs, sweeteners, starch, wheat, or yeast added
Adults ¡VTake 1 Capsule in the morning and 1 capsule in the evening.
Caution and Warning
Consult a health care practitioner prior to use if you have allergies or hypersensitivity to soy products
Consult your doctor before use if you have impaired thyroid function
Do not use if you have breast cancer or if breast cancer runs in your family
Do not use if you have endometrial cancer
Do not use if you have a risk of urinary bladder cancer
Do not use if you are pregnant or breastfeeding
Do not use in Children
Consult your health care practitioner prior to use if you are taking estrogen pills
(This product is not intended to replace any prescription medication and/or treat medical conditions. Consult a health care practitioner if sympton persists).
